Hiroomi Tada's most recent trade in Tyra Biosciences Inc was a trade of 1,968 Common Stock done at an average price of $6.6 . Disclosure was reported to the exchange on March 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 15 Mar 2024 | 1,968 | 86,435 | - | 6.6 | 12,947 | Common Stock | |
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 28 Jul 2023 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 15 Mar 2023 | 1,893 | 83,130 | - | 6.6 | 12,454 | Common Stock | |
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 15 Sep 2022 | 612 | 81,237 | - | 7.7 | 4,687 | Common Stock | |
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 06 Sep 2022 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 06 Sep 2022 | 2,703 | 80,625 | - | 8.5 | 23,044 | Common Stock | |
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 02 Nov 2021 | 83,626 | 83,626 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 02 Nov 2021 | 7,964 | 7,964 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Hiroomi Tada | Chief Medical Officer | 02 Nov 2021 | 7,964 | 7,964 | - | - | Stock Option (Right to Buy) |